Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Conditions: Schizophrenia; Schizoaffective Disorder, Depressive Type; Schizophreniform Disorder Interventions: Drug: Aripiprazole Lauroxil; Drug: ARI-ORAL; Drug: AL-NCD Sponsors: University of California, Los Angeles; Alkermes, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials